Beta blockers, statins and recommended doses of ACE-I improve survival in non-randomized patients with heart failure. A propensity score analysis of the Norwegian Heart Failure Registry

被引:0
|
作者
De Blois, J. [1 ]
Fagerland, M. Wang [2 ]
Grundtvig, M. [3 ]
Gullestad, L. [4 ]
Westheim, A. [5 ]
Hole, T. [6 ]
Atar, D. [1 ]
Agewall, S. [1 ]
机构
[1] Univ Oslo, Fac Div Aker Univ Hosp, Dept Cardiol, Oslo, Norway
[2] Ullevaal Univ Hosp, Clin Res Ctr, Unit Epidemiol & Biostat, Oslo, Norway
[3] Innlandet Hosp Trust Lillehammer, Dept Med, Lillehammer, Norway
[4] Univ Oslo, Fac Div Rikshosp Univ Hosp, Dept Cardiol, Oslo, Norway
[5] Univ Oslo, Fac Div Ulleval Univ Hosp, Dept Cardiol, Oslo, Norway
[6] Alesund Hosp, Dept Internal Med, Alesund, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:847 / 847
页数:1
相关论文
共 50 条
  • [21] Hyperuricaemia treatment in acute heart failure patients does not improve their long-term prognosis: a propensity score matched analysis from the AHEAD registry
    Miklikova, M.
    Jarkovsky, J.
    Benesova, K.
    Miklik, R.
    Felsoci, M.
    Spinar, J.
    Dusek, L.
    Parenica, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 958 - 958
  • [22] Hyperuricemia treatment in acute heart failure patients does not improve their long-term prognosis: A propensity score matched analysis from the AHEAD registry
    Pavlusova, Marie
    Jarkovsky, Jiri
    Benesova, Klara
    Vitovec, Jiri
    Linhart, Ales
    Widimsky, Petr
    Spinarova, Lenka
    Zeman, Kamil
    Belohlavek, Jan
    Malek, Filip
    Felsoci, Marian
    Kettner, Jiri
    Ostadal, Petr
    Cihalik, Cestmir
    Spac, Jiri
    Al-Hiti, Hikmet
    Fedorco, Marian
    Fojt, Richard
    Kruger, Andreas
    Malek, Josef
    Mikusova, Tereza
    Monhart, Zdenek
    Bohacova, Stanislava
    Pohludkova, Lidka
    Rohac, Filip
    Vaclavik, Jan
    Vondrakova, Dagmar
    Vyskocilova, Klaudia
    Bambuch, Miroslav
    Dostalova, Gabriela
    Havranek, Stepan
    Svobodova, Ivana
    Dusek, Ladislav
    Spinar, Jindrich
    Miklik, Roman
    Parenica, Jiri
    CLINICAL CARDIOLOGY, 2019, 42 (08) : 720 - 727
  • [23] Do beta-blockers improve one-year survival in heart failure patients with atrial fibrillation? Results from the ESC-HF Registry
    Ozieranski, K.
    Kaplon-Cieslicka, A.
    Balsam, P.
    Tyminska, A.
    Wancerz, A.
    Peller, M.
    Marchel, M.
    Crespo-Leiro, M. G.
    Maggioni, A. P.
    Drozdz, J.
    Filipiak, K. J.
    Opolski, G.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1027 - 1028
  • [24] Intravenous Inotropes, Beta Blockers and Survival in Ambulatory Heart Failure Patients - A Contemporary Analysis of 3,311 Patients
    Havakuk, O.
    Tran, J.
    Artig-Brown, T.
    Yoon, A.
    Fong, M. W.
    Meaux, N.
    Grazette, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S202 - S202
  • [25] Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure A Propensity Score-Matching Analysis Based on the EAHFE Registry
    Miro, Oscar
    Gil, Victor
    Martin-Sanchez, Francisco J.
    Herrero-Puente, Pablo
    Jacob, Javier
    Mebazaa, Alexandre
    Harjola, Veli-Pekka
    Rios, Jose
    Hollander, Judd E.
    Frank Peacock, W.
    Llorens, Pere
    CHEST, 2017, 152 (04) : 821 - 832
  • [26] Should beta-blockers be used before ACE inhibitors in patients with chronic heart failure? meta-analysis of the prognostic benefit conferred by beta-blockers in patients not receiving ACE inhibitors
    Haas, SJ
    Vos, T
    Krum, H
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (5-6) : A8 - A9
  • [27] Analysis of the effectiveness and safety of short-stay units in the hospitalization of patients with acute heart failure. Propensity Score SSU-EAHFE
    Sanchez-Marcos, C.
    Jacob, J.
    Llorens, P.
    Rodriguez, B.
    Martin-Sanchez, F. J.
    Herrera, S.
    Castillero-Diaz, L. E.
    Herrero, P.
    Gil, V
    Miro, O.
    REVISTA CLINICA ESPANOLA, 2022, 222 (08): : 443 - 457
  • [28] Beta-blockers for primary prevention of heart failure in patients with hypertension: A meta-analysis of randomized controlled trials
    Bangalore, Sripal
    Wild, David
    Parkar, Sanobar
    Kukin, Marrick
    Messerli, Franz H.
    CIRCULATION, 2007, 116 (16) : 457 - 457
  • [29] Beta-blockers do not reduce cardiovascular events in patients with CAD and an LVEF > 40%: A propensity-score matched analysis of patients hospitalized for acute heart failure
    Khalil, C. Charbel Abi
    Sulaiman, K.
    Asaad, N.
    Alhabib, K.
    Alsheikh-Ali, A.
    Jameesh, M.
    Al-Jarallah, M.
    Bulbanat, B.
    Almahmeed, W.
    Amin, H.
    Al-Motarreb, A.
    Alfaleh, H.
    Panduranga, P.
    Mahfoud, Z.
    Al Suwaidi, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 118 - 118
  • [30] Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry
    Schrage, Benedikt
    Uijl, Alicia
    Benson, Lina
    Westermann, Dirk
    Stahlberg, Marcus
    Stolfo, Davide
    Dahlstrom, Ulf
    Linde, Cecilia
    Braunschweig, Frieder
    Savarese, Gianluigi
    CIRCULATION, 2019, 140 (19) : 1530 - 1539